Antibiotic resistance surveillance over a 4-year period (2000–2003) in Turkey: results of the MYSTIC Program
- 31 December 2007
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 59 (4), 453-457
- https://doi.org/10.1016/j.diagmicrobio.2007.06.016
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997–2004Diagnostic Microbiology and Infectious Disease, 2005
- Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999–2003)Diagnostic Microbiology and Infectious Disease, 2004
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- Appropriate Empirical Antibacterial Therapy for Nosocomial InfectionsDrugs, 2003
- MYSTIC program: summary of European data from 1997 to 2000Diagnostic Microbiology and Infectious Disease, 2001
- MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: comparison of antibiotic susceptibilities between countries and centre typesJournal of Antimicrobial Chemotherapy, 2000
- Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997–1998Journal of Antimicrobial Chemotherapy, 2000
- Antimicrobial resistance in developing countriesBMJ, 1998
- Important and Emerging β-Lactamase-mediated Resistances in Hospital-based Pathogens: The Amp C EnzymesDiagnostic Microbiology and Infectious Disease, 1998
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988